Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy versus trichloroacetic acid plus cryotherapy for plantar warts
ACTRN12626000419369Phase 4Recruiting
- Sponsor
- PNS Shifa
- Start
- Apr 2026
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of trichloroacetic acid and nitrogen in plantar wart (2 arms), sponsored by PNS Shifa. Primary endpoint: Treatment response. Started Apr 2026; status: recruiting.
02
Drugs
trichloroacetic acidnitrogen
03
Conditions
plantar wart
Beyond the preview
Go deeper on ACTRN12626000419369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000419369.